GlaxoSmithKline Current Ratio 2006-2019 | GSK

Current and historical current ratio for GlaxoSmithKline (GSK) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. GlaxoSmithKline current ratio for the three months ending September 30, 2019 was 0.82.
GlaxoSmithKline Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $25.88B $31.46B 0.82
2019-06-30 $23.44B $33.14B 0.71
2019-03-31 $22.83B $31.86B 0.72
2018-12-31 $22.59B $30.02B 0.75
2018-09-30 $22.70B $23.97B 0.95
2018-06-30 $23.20B $24.77B 0.94
2018-03-31 $22.85B $37.47B 0.61
2017-12-31 $20.50B $34.24B 0.60
2017-09-30 $23.12B $35.92B 0.64
2017-06-30 $21.01B $36.81B 0.57
2017-03-31 $20.79B $23.23B 0.90
2016-12-31 $22.65B $25.75B 0.88
2016-09-30 $23.13B $23.82B 0.97
2016-06-30 $24.22B $25.98B 0.93
2016-03-31 $22.68B $19.94B 1.14
2015-12-31 $25.36B $20.52B 1.24
2015-09-30 $26.33B $19.77B 1.33
2015-06-30 $27.75B $21.13B 1.31
2015-03-31 $31.63B $23.93B 1.32
2014-12-31 $24.19B $21.91B 1.10
2014-09-30 $24.83B $25.52B 0.97
2014-06-30 $22.81B $20.62B 1.11
2014-03-31 $21.92B $19.31B 1.14
2013-12-31 $23.83B $21.40B 1.11
2013-09-30 $20.88B $19.89B 1.05
2013-06-30 $20.64B $19.17B 1.08
2013-03-31 $21.93B $18.66B 1.18
2012-12-31 $21.70B $21.90B 0.99
2012-09-30 $21.32B $22.06B 0.97
2012-06-30 $27.34B $24.39B 1.12
2012-03-31 $25.57B $22.83B 1.12
2011-12-31 $25.94B $24.08B 1.08
2011-09-30 $26.43B $21.13B 1.25
2011-06-30 $26.62B $22.23B 1.20
2011-03-31 $26.90B $20.99B 1.28
2010-12-31 $24.80B $19.51B 1.27
2010-09-30 $26.03B $17.42B 1.49
2010-06-30 $25.48B $17.91B 1.42
2010-03-31 $28.66B $18.98B 1.51
2009-12-31 $27.51B $18.98B 1.45
2009-09-30 $28.47B $18.26B 1.56
2009-06-30 $23.61B $13.99B 1.69
2009-03-31 $24.40B $14.02B 1.74
2008-12-31 $32.03B $18.58B 1.72
2008-09-30 $28.37B $16.69B 1.70
2008-06-30 $28.95B $16.30B 1.78
2008-03-31 $24.94B $18.47B 1.35
2007-12-31 $27.27B $20.70B 1.32
2007-09-30 $23.00B $18.25B 1.26
2007-06-30 $21.78B $14.31B 1.52
2007-03-31 $14.22B $9.75B 1.46
2006-12-31 $20.26B $13.39B 1.51
2006-09-30 $22.30B $13.67B 1.63
2006-06-30 $23.12B $15.07B 1.53
2006-03-31 $24.44B $16.38B 1.49
2005-12-31 $24.00B $17.32B 1.39
2005-09-30 $23.86B $15.96B 1.50
2005-06-30 $22.79B $15.66B 1.46
2005-03-31 $21.51B $17.76B 1.21
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $117.802B $41.140B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.359B 17.09
Roche Holding AG (RHHBY) Switzerland $282.158B 0.00
Pfizer (PFE) United States $220.369B 13.10
Merck (MRK) United States $218.904B 16.96
Novartis AG (NVS) Switzerland $215.131B 18.16
Novo Nordisk (NVO) Denmark $144.638B 24.93
Eli Lilly (LLY) United States $133.525B 24.66
AstraZeneca (AZN) United Kingdom $129.299B 23.35
AbbVie (ABBV) United States $123.541B 9.68
Sanofi (SNY) France $122.027B 14.99
Bristol-Myers Squibb (BMY) United States $104.535B 14.61
Bayer (BAYRY) Germany $77.588B 11.49
H Lundbeck (HLUYY) Denmark $8.147B 14.16